Division of Anaesthesiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Division of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Anaesthesiol Intensive Ther. 2021;53(3):271-273. doi: 10.5114/ait.2020.100300.
his letter discusses precautions regarding the waterproof structure of the oximetry central venous catheter (CVC) shaft and the risk of blood reflux and leakage that can occur when the catheter shaft is cut. To assess oxygen supply-demand balance [1] and haemodynamics [2], the Swan-Ganz pulmonary artery catheter has been used for perioperative and postoperative management and treatment of critically ill patients for a half a century. In current clinical practice, haemodynamic parameters such as stroke volume (SV) and cardiac output (CO), as well as central venous oxygen saturation (ScvO2), can be measured continuously using a combination of FloTrac Sensor (Edwards Lifesciences Japan Ltd., Tokyo, Japan) [3], Edwards PreSep Oximetry Catheter (Edwards Lifesciences Japan Ltd., Tokyo, Japan) [4], and EV1000 Clinical Platform (Edwards Lifesciences Japan Ltd., Tokyo, Japan) or Vigileo Monitor (Edwards Lifesciences Japan Ltd., Tokyo, Japan) [5, 6]. These methods are less invasive than the Swan-Ganz pulmonary artery catheter, and the changes in the parameter values can be used as an index for perioperative management in both cardiovascular and non-cardiovascular surgeries. In addition, they can be used for the treatment of critically ill patients in the intensive care unit, enabling proactive determination of an appropriate therapy [7]. Compared to intermittent sampling and traditional vital signs alone, continuous ScvO2 monitoring is a more sensitive indicator of tissue perfusion because it reveals the true adequacy of tissue oxygenation, enabling early detection and assessment of clinical response to intervention [7, 8].
他的信中讨论了血氧计中央静脉导管(CVC)轴的防水结构的注意事项,以及当导管轴被切割时可能发生的血液回流和泄漏的风险。为了评估氧供需平衡[1]和血液动力学[2],Swan-Ganz 肺动脉导管已在半个世纪以来用于围手术期和术后管理以及危重病患者的治疗。在当前的临床实践中,可以使用 FloTrac 传感器(Edwards Lifesciences Japan Ltd.,东京,日本)[3]、Edwards PreSep 血氧计导管(Edwards Lifesciences Japan Ltd.,东京,日本)[4]和 EV1000 临床平台(Edwards Lifesciences Japan Ltd.,东京,日本)或 Vigileo 监护仪(Edwards Lifesciences Japan Ltd.,东京,日本)[5,6]连续测量心排量(SV)和心输出量(CO)以及中心静脉血氧饱和度(ScvO2)等血液动力学参数。这些方法比 Swan-Ganz 肺动脉导管侵入性更小,参数值的变化可作为心血管和非心血管手术围手术期管理的指标。此外,它们可用于重症监护病房的危重病患者的治疗,能够主动确定适当的治疗方法[7]。与间歇采样和传统生命体征相比,连续 ScvO2 监测是组织灌注的更敏感指标,因为它揭示了组织氧合的真实充足性,能够早期发现并评估临床对干预的反应[7,8]。